<p>Nanomicellar Lenalidomide–Fenretinide Combination Suppresses Tumor Growth in an <em>MYCN</em> Amplified Neuroblastoma Tumor</p>
Isabella Orienti(University of Bologna), Garrett M. Brodeur(Children's Hospital of Philadelphia)
Cited by 8
Related Papers
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
|Cell Death and Disease|2019|57
RET receptor expression and interaction with TRK receptors in neuroblastomas
|Oncology Reports|2020|17